Blog
About

17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A novel painkiller nanomedicine triggers the specific delivery of enkephalin neuropeptide into inflamed tissues.

          Abstract

          The clinical use of endogenous neuropeptides has historically been limited due to pharmacokinetic issues, including plasma stability and blood-brain barrier permeability. In this study, we show that the rapidly metabolized Leu-enkephalin (LENK) neuropeptide may become pharmacologically efficient owing to a simple conjugation with the lipid squalene (SQ). The corresponding LENK-SQ bioconjugates were synthesized using different chemical linkers in order to modulate the LENK release after their formulation into nanoparticles. This new SQ-based nanoformulation prevented rapid plasma degradation of LENK and conferred on the released neuropeptide a notable antihyperalgesic effect that lasted longer than after treatment with morphine in a rat model of inflammation (Hargreaves test). The biodistribution study as well as the use of brain-permeant and -impermeant opioid receptor antagonists indicated that LENK-SQ NPs act through peripherally located opioid receptors. This study represents a novel nanomedicine approach, allowing the specific delivery of LENK neuropeptide into inflamed tissues for pain control.

          Related collections

          Most cited references 40

          • Record: found
          • Abstract: not found
          • Article: not found

          Ethical guidelines for investigations of experimental pain in conscious animals.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.

            A method to measure cutaneous hyperalgesia to thermal stimulation in unrestrained animals is described. The testing paradigm uses an automated detection of the behavioral end-point; repeated testing does not contribute to the development of the observed hyperalgesia. Carrageenan-induced inflammation resulted in significantly shorter paw withdrawal latencies as compared to saline-treated paws and these latency changes corresponded to a decreased thermal nociceptive threshold. Both the thermal method and the Randall-Selitto mechanical method detected dose-related hyperalgesia and its blockade by either morphine or indomethacin. However, the thermal method showed greater bioassay sensitivity and allowed for the measurement of other behavioral parameters in addition to the nociceptive threshold.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Ethical guidelines for investigations of experimental pain in conscious animals

                Bookmark

                Author and article information

                Journal
                Sci Adv
                Sci Adv
                SciAdv
                advances
                Science Advances
                American Association for the Advancement of Science
                2375-2548
                February 2019
                13 February 2019
                : 5
                : 2
                Affiliations
                [1 ]Institut Galien Paris-Sud, UMR8612, Univ. Paris-Sud, Université Paris-Saclay, Châtenay-Malabry 92290, France.
                [2 ]Centre de Psychiatrie et Neurosciences, INSERM UMR 894, Université Paris Descartes, 75014 Paris, France.
                [3 ]Laboratoire de Neuropharmacologie, INSERM UMRS 1178, Univ. Paris-Sud, Université Paris-Saclay, Châtenay-Malabry 92290, France.
                Author notes
                [* ]Corresponding author. Email: patrick.couvreur@ 123456u-psud.fr
                Article
                aau5148
                10.1126/sciadv.aau5148
                6374102
                30788432
                Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

                Funding
                Funded by: doi http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: 249835
                Funded by: RBUCE-UP;
                Award ID: 00001002483/78
                Categories
                Research Article
                Research Articles
                SciAdv r-articles
                Health and Medicine
                Applied Sciences and Engineering
                Health and Medicine
                Custom metadata
                Eunice Ann Alesin

                Comments

                Comment on this article